vyd2311
·Code: VYD2311
vyd2311: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Invivyd, Inc. (IVVD) | Phase 3 |
FDA Decisions
FDA_MeetingThe company received U.S. IND clearance and reached alignment with the U.S. FDA on a pivotal clinical program for VYD2311.(IVVD)
Frequently asked questions
Who is developing vyd2311?
vyd2311 is being developed by Invivyd, Inc..
What is vyd2311's latest FDA decision?
The most recent tracked FDA decision for vyd2311 is FDA_Meeting for The company received U.S. IND clearance and reached alignment with the U.S. FDA on a pivotal clinical program for VYD2311., dated October 6, 2025.
Get deeper analysis on vyd2311
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis